4 курс / Акушерство и гинекология / Гиперпластические_процессы_эндометрия_Русакевич_П_С_

Гиперпластические процессы эндометрия

well differentiated carcinoma // Cancer (Philad.).– 1982.– Vol. 49.– P. 2547–2559.

359.La Sala G.B., Montanari R., Dessanti L. The role of diagnostic hysterscopy and endometrial biopsy in assisted reproductive technologies // Fertil. Steril. — 1998.– Vol. 70, № 4.– P. 378–380.

360.LaneG.,SiddleN.,RyderT.A.etal.Effectsofdydrogesterone on the oestrogenized postmenopausal endometrium // Br. J. Obstet. Gynecol.– 1986.– Vol. 93.– P. 55–62.

361.Latheenmaki P., Bardin C., Eloma K. et al. Selection and performance of the levonorgestrel-releasing intrauterine system

//Obstet. Gyneaecol. Scand.– 1997.– Vol. 164.– P. 69–74.

362.Lewis B.V. Hysteroscopy in clinical practice // J. Obstet. Gynecol.– 1988.– Vol. 9.– P. 47.

363.Lewy T., Gurevitch S., Bar-Hava I. Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet // Hum. Reprod.– 2000.– Vol. 14, № 3.–P. 2596.

364.Lidegaard O., Edstrom B., Kreiner S. Oral contraceptives and venous thromboembolism, a case-control study // Contraception.– 1998.– Vol. 57.– P. 291–301.

365.Loffer F.D. Endometrial ablation – where do we stand ? // Gynecol. Endosc.–1992.– Vol. 2.– P. 1.

366.Lucas D., Klentzeris L.D. Роль эндометрия в имплантации // Пробл. репрод.– 1999.– № 2.–С. 27–32.

367.Luukkainen T., Allonen H., Haukkamaa et al. Five years experience with levonorgestrel-releasing devices // Contraception.– 1986.– Vol. 33.– P. 139–148.

368.Mango D., Ricci S., Manna P., Miggiano G.A. Clinical and hormonal effects of ethinylestradiol combined with gestogene and desogestrel in young women with acne vulgares // Contraception.– 1996.– Vol. 53.– P. 163– 170.

369.Mark S.A.U. Premenopasal bone loss and depot medroxyprogesteroneacetateadministration//Int.J.Gynecol. Obstet.– 1994.– Vol. 47, №3.– P. 269–272.

370.Mazur M.T. Endometrial hyperplasia/adenocarcinoma a conventional approach // Ann. Diagn. Pathol.– 2005.– Vol. 9.– P. 174–181.

Список литературы

371.Meiver B., Romanski S.A., Nippoldt T.B. Evolution and management of amenorrhea // Mayo Clein Proc.– 1997.– Vol. 72, №12.– P. 1161–1169.

372.Meriggiola M., Brenner W., Paulsen C. Cyproterone acetate and testosterone enantate as a potentially highly effective male contraceptive // J. Clin. Endocrinol. Metab.– 1996.– Vol. 81.– P. 3018–3023.

373.Minarjez D.A., Bradshaw K.D. Abnormal uterine bleeding in adolescents // Obstet. Gynecol. Clin.– 2000.– Vol. 27, № 1.– P. 109–112.

374.Mitan L.A., Slap G.B. Adolescent menstrual disorders // Med. Clin. North Am.– 2000.– Vol. 84.– P. 4.

375.Moore C., Kohler G., Muller A. The treatment of endometriosis with dienogest // Drug of today.– 1999.– Vol. 35 (Suppl. C).– P. 69–79.

376.Newton J. Classification and comparison of oral contraceptives containing new generation progestogens // Hum. Reprod. Update.– 1995.– Vol. 1.– P. 231–263.

vivo activities of norgestimate and other progestins // Contraception.– 1990.– Vol. 41.– P. 399–410.

379.Pike M.C., Ross R.K. Progestogens and menopause // Steroids.– 2000.– Vol. 65.– P. 59–64.

380.Pollow K., Juchem M. Gestogene: a novel synthetic progestincharacterization of binding to receptor and serum proteins // Contraception.– 1989.– Vol. 40.– № 3.– P. 325–341.

381.Rothe K. Gestagene und corpus-luteum-insuffizienz // Zentralbl. Gynakol.– 1995.– Vol. 117.– P. 2–5.

382.RozenbaumH.Definitionandparticularitiecofperimenopause // Menopause Review.– 2000.– Vol. 5, № 1.– P. 6.

Гиперпластические процессы эндометрия

383.Rozenbaum H. Progestins and endometrial safety // Drags Today.– 1996.–Vol. 32 (Suppl. H).– P. 15–23.

Am. J. Obstet. Gynecol.– 1998.– Vol. 179.– P. 577–582.

385.Rutanen E.M. Endometrial response to intrauterine release of levonorgestrel // Gynecology Forum.– 1998.– Vol. 3, №. 3.– P. 11–13.

386.Rybo G. Treatment of menorrhagia using intrauterine administration of levonorgestrel // Gynecology Forum.– 1998.– Vol. 3, № 3.– P. 20–22.

387.Schindler А.E. Role of progestins in the premenopausal climacteric // Gynecol. Endocrinology.–1999.– Vol. 13 (suppl. 6).– P. 35–40.

388.Schindler А.E., Compagnoli C. et al. Aspectsofprogestinactivity on the brest // Maturitas.– 1998.– Vol. 29.– P. 61–65.

389.Scully R.E., BonfiglioT.A., Kurman R.J. et al. Histological typing of female genital tract tumours (International histological Classification of tumours).– 2nd.– Ed. WHO, Geneva.– 1994.– P. 13–18.

390.Spitzer W.O., Lewis M.A., Heinemann L.A.J. Third generation oral contraceptives and risk of venous thromboembolic disorders: Fn international case-control study // BMJ.–1996.–Vol. 312.– P. 83.

391.Stanczyk F. Structure-function relationships, metabolism, pharmacokinetics and potency of progestins // Drug of Today.– 1996.– Vol. 32 (suppl. H).– P. 1–14.

392.Stewart A. et al. The effectiveness of the levonorgestrelreleasing intrauterine system in menorrhagia: a systematic review // BJOG: an International Journal of Obstetrics and Gynecology.– 2001.– Vol. 108.– P. 74–86.

393.Sturridge F., Guillebaund J. Gynecological aspects of the levonorgestrel-releasing intrauterine system // Brit. J. Obstet. Gynecol.– 1997.– Vol. 104, № 3.– P. 285–289.

394.Subonen S., Holmstrom T., Allonen H. et al. Intrauterne and subdermal progestin administration in postmenopausal hormone replacement therapy // Fertil. Steril.– 1995.– Vol. 63.– P. 336–342.

Список литературы

395.Taylor P.J., Gordon A.G. Practical hysteroscopy.– Blacwell Scientific Publification.– Oxford, 1993.–677 s.

396.The formulation of the current management of patients with atypical hyperplasia / G. Gorchev, V. Milkov, I. Popov, E. Rachev // Akush. Ginecol. Sofia.– 1998.– Vol. 32, № 3.– P. 30–31.

397.The pathogenetic basis for using antiestrogens in treating patients with hyperplastic processes of the endometrium in the postmenopause / M. Vysotskii, I. Krasnova, O. Rostyleva et al. // Akush. Ginecol. Mosk.– 1993.– № 6.– P. 46–49.

398.Thorneycroft I.H. Cycle control with oral contraceptives: A review of the literature // Am. J. Obstet. Gynecol.– 1999.– Vol. 180, № 1.– P. 280–287.

399.Thorneycroft I.H. Update on androgenicity // Am. J. Obstet. Gynecol.– 1999.– Vol. 180, № 1.– P. 288–294.

400.Timor-Tritsch I.E., Rottem S. Transvaginal sonography.–

New-York, 1991.– 689 s.

401.Toivonen J., Luukkainen T., Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years comparative experience of levonorgestrel and copper–releasing intrauterine devices // Obstet. Gynecol.– 1991.– Vol. 77, № 2.– P. 261–264.

402.TrattamentoconGnRHanaloghidellaiperplasiaendometriali semplice.Valutazionediunostudiopolicentricoambulatoriale. Risultati preliminary / R. Zagni, R. Cortelazzi, L. Cipolla // Minerva Ginecol.– 1993.– Vol. 45, № 12.– P. 597–602.

403.Ultrasound and the Endometrium / Ed. by Fleisher A.C., Kurjak A., Granberg S.N.Y.; L.: The Parthenon Publishing gr., 1997. –344 p.

404.Westhoff C.L. Oral contraceptives and breast cancer – resolution emerges // Contraception.– 1996.– Vol. 54 (Suppl. 3).– P. 1–2.

405.Whitehead M.I., Hillard T.C., Crook D. The role and use of progestogens // Obstet. Gynecol.– 1990.– Vol. 75.– P. 59–76.

406.Zimmermann T., Duvauchelle T., Gualano V. et al.

Pharmacjkinetics of dienogest as a single drug or in combination with estradiol valerate or ethinilestradiol // Drug of Today.– 1999.– Vol. 35(suppl.C).– P. 27–39.